2025/07/15 by Sheera R. Rosenbaum, Kaiah M. Fields, Heide L. Ford · 1 voice · 1 citation
Medicine · #Cancer Cells and Metastasis #Cancer Immunotherapy and Biomarkers #Cancer, Stress, Anesthesia, and Immune Response
paper · pdf · doi:10.1371/journal.pbio.3003301
openalex publication_date 2025/07/15 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/01
One of the greatest challenges to cancer therapy is tumor cell plasticity. Cancer cells can rapidly alter their phenotype to promote survival and evade immune cell attack, while the plasticity of other cells in the tumor microenvironment (such as immune cells, which need to be able to respond to a diverse range of bodily threats) can be leveraged to further promote tumor growth and progression. This Essay discusses the mutual plasticity of cancer and immune cells, with a focus on epithelial-mesenchymal plasticity in tumor cells, and explores how this interplay contributes to tumor progression and can be targeted therapeutically.